ZA200701081B - Selected fused heterocyclics and uses thereof - Google Patents

Selected fused heterocyclics and uses thereof

Info

Publication number
ZA200701081B
ZA200701081B ZA200701081A ZA200701081A ZA200701081B ZA 200701081 B ZA200701081 B ZA 200701081B ZA 200701081 A ZA200701081 A ZA 200701081A ZA 200701081 A ZA200701081 A ZA 200701081A ZA 200701081 B ZA200701081 B ZA 200701081B
Authority
ZA
South Africa
Prior art keywords
selected fused
fused heterocyclics
heterocyclics
fused
Prior art date
Application number
ZA200701081A
Other languages
English (en)
Inventor
Aquila Brian
Block Michael Howard
Davies Audrey
Ezhuthachan Jayachandran
Pontz Timothy
Russell Daniel John
Theoclitou Marie-Elena
Zheng Xiaolan
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35004223&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200701081(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200701081B publication Critical patent/ZA200701081B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA200701081A 2004-08-18 2007-02-06 Selected fused heterocyclics and uses thereof ZA200701081B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60239904P 2004-08-18 2004-08-18

Publications (1)

Publication Number Publication Date
ZA200701081B true ZA200701081B (en) 2008-08-27

Family

ID=35004223

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200701081A ZA200701081B (en) 2004-08-18 2007-02-06 Selected fused heterocyclics and uses thereof

Country Status (19)

Country Link
US (1) US20070249636A1 (de)
EP (1) EP1781673B1 (de)
JP (1) JP2008509976A (de)
KR (1) KR20070046175A (de)
CN (1) CN101023086A (de)
AR (1) AR050921A1 (de)
AT (1) ATE446301T1 (de)
AU (1) AU2005273704A1 (de)
BR (1) BRPI0514398A (de)
CA (1) CA2575056A1 (de)
DE (1) DE602005017283D1 (de)
IL (1) IL180811A0 (de)
MX (1) MX2007001954A (de)
NO (1) NO20070980L (de)
RU (1) RU2007109867A (de)
TW (1) TW200621260A (de)
UY (1) UY29074A1 (de)
WO (1) WO2006018627A1 (de)
ZA (1) ZA200701081B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007001953A (es) 2004-08-18 2007-05-09 Astrazeneca Ab Enantiomeros de pirimidonas fusionadas seleccionadas y usos en el tratamiento y prevencion del cancer.
ATE474829T1 (de) * 2005-06-27 2010-08-15 Amgen Inc Entzündungshemmende arylnitrilverbindungen
KR101565971B1 (ko) * 2007-06-21 2015-11-05 뉴로내슨트, 아이엔씨. 이소티아졸로피리미디논을 사용하는 신경 발생을 자극하고 신경 변성을 억제하는 방법 및 조성물
ES2569215T3 (es) 2007-09-10 2016-05-09 Boston Biomedical, Inc. Un nuevo grupo de inhibidores de la ruta de Stat3 e inhibidores de la ruta de las células madre del cáncer
US8796460B2 (en) 2007-10-19 2014-08-05 Mercky Sharp & Dohme Corp. Compounds for inhibiting KSP kinesin activity
CA2908380A1 (en) 2013-04-09 2014-10-16 Boston Biomedical, Inc. Methods for treating cancer
US11299469B2 (en) 2016-11-29 2022-04-12 Sumitomo Dainippon Pharma Oncology, Inc. Naphthofuran derivatives, preparation, and methods of use thereof
JP2020520923A (ja) 2017-05-17 2020-07-16 ボストン バイオメディカル， インコーポレイテッド がんを処置するための方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003049527A2 (en) * 2001-12-06 2003-06-19 Merck & Co., Inc. Mitotic kinesin inhibitors
ATE447577T1 (de) * 2001-12-06 2009-11-15 Merck & Co Inc Mitotische kinesin-hemmer
CA2482041C (en) * 2002-04-17 2012-06-05 Cytokinetics, Inc. 4-chromanone derivatives for treating cellular proliferative diseases and disorders
DK1601673T3 (da) * 2003-03-07 2009-08-24 Astrazeneca Ab Kondenserede heterocykler og anvendelser af disse
US7022850B2 (en) * 2003-05-22 2006-04-04 Bristol-Myers Squibb Co. Bicyclicpyrimidones and their use to treat diseases
US7345046B2 (en) * 2003-05-30 2008-03-18 Chiron Corporation Heteroaryl-fused pyrimidinyl compounds as anticancer agents

Also Published As

Publication number Publication date
RU2007109867A (ru) 2008-09-27
ATE446301T1 (de) 2009-11-15
AU2005273704A1 (en) 2006-02-23
UY29074A1 (es) 2006-03-31
NO20070980L (no) 2007-03-12
US20070249636A1 (en) 2007-10-25
AR050921A1 (es) 2006-12-06
EP1781673B1 (de) 2009-10-21
DE602005017283D1 (de) 2009-12-03
MX2007001954A (es) 2007-05-09
CN101023086A (zh) 2007-08-22
TW200621260A (en) 2006-07-01
IL180811A0 (en) 2007-06-03
BRPI0514398A (pt) 2008-06-10
CA2575056A1 (en) 2006-02-23
JP2008509976A (ja) 2008-04-03
EP1781673A1 (de) 2007-05-09
WO2006018627A1 (en) 2006-02-23
KR20070046175A (ko) 2007-05-02

Similar Documents

Publication Publication Date Title
EP1802588A4 (de) Substituierte aminopyrimidone und anwendungen davon
EP1831170A4 (de) Substituierte aminopyridine und deren verwendung
EP1802587A4 (de) Substituierte aminoverbindungen und deren anwendungen
PL1830872T3 (pl) Białka fuzyjne
GB0426397D0 (en) Fusion proteins
IL179300A0 (en) Novel-antigen-binding polypeptides and their uses
IL182554A0 (en) Anti-addl antibodies and uses thereof
EP1731134A4 (de) Funktionale pulver
IL189609A0 (en) 4-substituted pyrrolidin-2-ones and their use
IL178277A0 (en) Irta-5 antibodies and their uses
IL180596A0 (en) Field labeled button
HK1137439A1 (en) Fused pyrrolocarbazoles and methods for the preparation thereof
EP1824467A4 (de) Apogossypolon und dessen verwendungen
IL179497A0 (en) Carboranylporphyrins and uses thereof
TWI315940B (en) Improved tie-high and tie-low circuit
HK1084390A1 (en) Fused heterocycles and uses thereof
ZA200701081B (en) Selected fused heterocyclics and uses thereof
ZA200703406B (en) Anti-ADDL antibodies and uses thereof
PL2215908T3 (pl) 2-alkilo-cykloalk(en)ylo-karboksamidy i ich zastosowanie jako fungicydów
EP1737565A4 (de) Cos-claus-konfigurationen und -verfahren
IL180365A0 (en) Carboranylporphyrins and uses thereof
EP1943350A4 (de) Latente procytotoxine und anwendungen davon
EP1761256A4 (de) Cla-angereichertes milchfett und seine verwendungen
ZA200605668B (en) Fused pyrrolocarbazoles and methods for the preparation thereof
TWI365449B (en) Case member and cartridge